<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75450">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01770444</url>
  </required_header>
  <id_info>
    <org_study_id>B-1211/177-005</org_study_id>
    <nct_id>NCT01770444</nct_id>
  </id_info>
  <brief_title>Low-Dose Coronary Computed Tomographic Angiography for Early Triage of Acute Chest Pain</brief_title>
  <official_title>Safety and Efficacy of Implementing Low-Dose Coronary Computed Tomographic Angiography for Early Triage of Acute Chest Pain in Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to see whether the low-dose coronary  computed tomographic angiography (CCTA)
      protocol is as safe and efficacious as conventional-dose protocol in early triage of acute
      chest pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, CCTA is a valuable tool for early triage of low to intermediate risk acute chest
      pain patients in emergency department. However, it has been criticized for causing
      unnecessary radiation exposure in the population where its majority has no coronary lesion.
      A low-dose CCTA protocol comprised with 1) dedicated cardiac imaging protocol (rather than
      triple rule-out protocol), 2) retrospective gating and 3) without additional imaging for
      calcium scoring will be used to implement the low-dose imaging. We hypothesized that the
      low-dose CCTA protocol will be as safe and efficacious as conventional dose protocol while
      decreasing the amount of radiation exposure significantly.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Proportion of patients having hard events (death, MI) after negative low-dose CCTA findings</measure>
    <time_frame>Within one month after discharge from emergency department</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Direct comparison of accuracy (sensitivity, specificity, PPV, NPV) for between low-dose and conventional cardiac CT</measure>
    <time_frame>One month after discharge from emergency department</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The diagnostic accuracy of detecting ACS will be assessed using patient chart review and telephone interview (48-72 hours and one month after discharge) as appropriate. ACS event (and MACE) will be adjudicated by independent cardiologists.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct comparison of frequency and overall cost of additional tests such as echocardiography, treadmill test, myocardial SPECT and coronary angiography</measure>
    <time_frame>During 1) index ED visit, which will be an average of 1 day and 2) one-month follow-up period after discharge</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total radiation dose exposed by index CT imaging and additional tests including SPECT and invasive angiography</measure>
    <time_frame>During 1) index ED visit, which will be an average of 1 day and 2) one-month follow-up period after discharge</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total length of ED and hospital stay</measure>
    <time_frame>Time spent for index ED visit, which will be an average of 24 hours and total hospital stay until discharge, which will be an average of 7 days.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">681</enrollment>
  <condition>Acute Chest Pain</condition>
  <arm_group>
    <arm_group_label>Low-dose cardiac CT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this group will be assessed by low-dose cardiac CT protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional cardiac CT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients randomized to this group will be assessed by conventional cardiac CT protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low-dose Cardiac CT protocol</intervention_name>
    <description>A cardiac CT protocol modified for reduction of radiation exposure
Prospective gating
Range: dedicated imaging (below carina to heart base)</description>
    <arm_group_label>Low-dose cardiac CT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional cardiac CT protocol</intervention_name>
    <description>Conventional CCTA protocol
Retrospective gating with tube current modulation
Range: dedicated imaging (below carina to heart base)</description>
    <arm_group_label>Conventional cardiac CT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients visiting emergency department for A) acute onset (&lt;12hr) chest pain or
        equivalent symptoms B) aged between 25-55, C) that requires to rule out acute coronary
        syndrome.

        Exclusion Criteria:

          1. Known coronary artery disease and/or any related intervention (STENT, CABG)

          2. Elevated cardiac biomarkers (CK-MB, Troponin I)

          3. Ischemic ECG changes

          4. Documented evidence of low LV systolic function (ejection fraction ≤ 45%)

          5. TIMI risk &gt;4

          6. Unstable vital sign (e.g. hypoxemia, shock)

          7. Patients with contraindication to iodinated contrast and/or beta blockers including
             renal failure or reactive airway diseases such as COPD or asthma

          8. Atrial fibrillation on initial ECGs

          9. Active renal disease, serum creatinine ≥1.5 mg/dl

         10. Negative coronary angiography or CCTA within 6 months

         11. Modified Wells criteria &gt;4 or D-dimer &gt; 0.5ug/mL

         12. Suspicious of aortic dissection or D-dimer &gt; 0.5ug/mL
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyuseok Kim, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of emergency medicine, Seoul national university Bundang hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sangil Choi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of radiology, Seoul national university Bundang hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyuseok Kim, MD</last_name>
    <phone>+82-31-787-7572</phone>
    <email>dremkks@snubh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joonghee Kim, MD</last_name>
    <phone>+82-10-9489-3696</phone>
    <email>joonghee@me.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul national university Bundang hospital</name>
      <address>
        <city>Seongnam-si</city>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyuseok Kim, MD</last_name>
      <phone>+82-31-787-7572</phone>
      <email>dremkks@snubh.org</email>
    </contact>
    <contact_backup>
      <last_name>Joonghee Kim, MD</last_name>
      <email>joonghee@me.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sang Il Choi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eun Ju Chun, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chang-Hwan Yoon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jung-Won Suh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul national university Boramae medical center</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jong Hwan Shin, MD</last_name>
      <email>skyshin1@dreamwiz.com</email>
    </contact>
    <investigator>
      <last_name>Jong Hwan Shin, skyshin1@dreamwiz.com</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kwang Nam Jin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joon-Won Kang, MD</last_name>
      <email>jwonkang@amc.seoul.kr</email>
    </contact>
    <investigator>
      <last_name>Won Young Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joon-Won Kang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dong Woo Seo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 14, 2014</lastchanged_date>
  <firstreceived_date>December 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute coronary syndrome</keyword>
  <keyword>Cardiac computed tomographic angiography</keyword>
  <keyword>Radiation dose reduction</keyword>
  <keyword>Medical radiation exposure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cytarabine</mesh_term>
    <mesh_term>Thioguanine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
